Needham analyst David Saxon has maintained their neutral stance on XRAY stock, giving a Hold rating today.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
David Saxon has given his Hold rating due to a combination of factors, including a top-line performance that exceeded expectations largely because of favorable foreign-exchange movements rather than stronger underlying demand. At the same time, earnings per share were slightly below consensus, indicating that profitability is not yet fully aligned with revenue performance.
Management reaffirmed its outlook and is progressing on the multi‑year Return to Growth initiative, which is intended to enhance commercial execution and support more durable growth by 2027. However, Saxon views the trajectory back to sustainable growth as potentially uneven and carrying execution risk, so he believes the risk‑reward profile is balanced at current levels, supporting a neutral, or Hold, stance.
Based on the recent corporate insider activity of 80 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of XRAY in relation to earlier this year.